27th May 2021 16:22
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 26 May 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
1,829,032 | 1.42% | 229,677 | 0.18% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
72,359 | 0.06% | 94,581 | 0.07% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
1,907,491 | 1.48% | 330,358 | 0.26% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 1 | 260.1000 USD |
Purchase | 2 | 260.2700 USD |
Purchase | 4 | 261.6100 USD |
Purchase | 10 | 261.2800 USD |
Purchase | 13 | 261.5400 USD |
Purchase | 15 | 260.5006 USD |
Purchase | 40 | 261.4200 USD |
Purchase | 80 | 255.9020 USD |
Purchase | 100 | 259.8480 USD |
Purchase | 111 | 259.8736 USD |
Purchase | 143 | 260.5912 USD |
Purchase | 200 | 260.2850 USD |
Purchase | 228 | 255.0200 USD |
Purchase | 248 | 260.0807 USD |
Purchase | 356 | 260.3684 USD |
Purchase | 400 | 260.7250 USD |
Purchase | 740 | 260.2833 USD |
Purchase | 950 | 260.3378 USD |
Purchase | 1,155 | 260.0600 USD |
Purchase | 1,162 | 261.4063 USD |
Purchase | 1,876 | 260.5507 USD |
Purchase | 2,000 | 260.5355 USD |
Purchase | 3,600 | 261.4011 USD |
Purchase | 8,531 | 260.4768 USD |
Purchase | 9,096 | 260.0683 USD |
Purchase | 30,741 | 260.6317 USD |
Purchase | 83,997 | 260.7827 USD |
Sale | 1 | 261.6700 USD |
Sale | 10 | 259.9800 USD |
Sale | 17 | 261.5565 USD |
Sale | 79 | 255.0200 USD |
Sale | 93 | 260.6000 USD |
Sale | 100 | 261.1100 USD |
Sale | 100 | 261.3400 USD |
Sale | 148 | 259.9678 USD |
Sale | 173 | 261.0841 USD |
Sale | 176 | 261.2397 USD |
Sale | 200 | 259.8800 USD |
Sale | 208 | 261.1778 USD |
Sale | 248 | 260.0807 USD |
Sale | 300 | 260.6900 USD |
Sale | 308 | 255.2490 USD |
Sale | 321 | 260.4157 USD |
Sale | 610 | 260.8288 USD |
Sale | 700 | 260.1628 USD |
Sale | 800 | 260.8006 USD |
Sale | 840 | 260.2311 USD |
Sale | 840 | 260.6188 USD |
Sale | 881 | 260.3899 USD |
Sale | 1,162 | 261.4063 USD |
Sale | 1,248 | 260.4027 USD |
Sale | 1,262 | 261.3955 USD |
Sale | 1,306 | 261.0624 USD |
Sale | 1,377 | 261.0406 USD |
Sale | 1,402 | 260.7286 USD |
Sale | 1,876 | 260.5507 USD |
Sale | 1,933 | 261.1375 USD |
Sale | 2,067 | 260.9248 USD |
Sale | 2,400 | 260.5671 USD |
Sale | 2,650 | 260.4286 USD |
Sale | 2,734 | 260.8591 USD |
Sale | 2,804 | 261.2847 USD |
Sale | 3,002 | 260.8084 USD |
Sale | 3,277 | 260.9605 USD |
Sale | 4,000 | 261.3991 USD |
Sale | 4,600 | 260.4471 USD |
Sale | 6,805 | 260.4967 USD |
Sale | 8,245 | 260.9654 USD |
Sale | 9,662 | 260.0600 USD |
Sale | 10,250 | 261.2579 USD |
Sale | 15,580 | 261.0765 USD |
Sale | 15,817 | 260.1782 USD |
Sale | 50,509 | 260.5819 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 27 May 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210527005682/en/
Copyright Business Wire 2021
Related Shares:
Barclays